Scielo RSS <![CDATA[Revista Panamericana de Salud Pública]]> http://www.scielosp.org/rss.php?pid=1020-498920100006&lang=en vol. 27 num. 6 lang. en <![CDATA[SciELO Logo]]> http://www.scielosp.org/img/en/fbpelogp.gif http://www.scielosp.org <![CDATA[<b>Verotoxin-producing <i>Escherichia coli</i></b>: <b> quantitative model of exposure and risk scenarios in cattle carcasses in Argentina</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600001&lng=en&nrm=iso&tlng=en OBJETIVOS: Cuantificar la contaminación por Escherichia coli verotoxigénica asociada con el síndrome urémico hemolítico (ECvt-SUH) en las canales de ganado bovino y generar estimaciones de exposición en tres escenarios probables. MÉTODOS: Se modeló la frecuencia y la magnitud de la contaminación por ECvt-SUH desde la producción primaria hasta la salida de las canales del frigorífico, a partir de la información científica publicada y datos epidemiológicos y de expertos locales. Las distribuciones de la probabilidad que mejor describieron cada paso del proceso y los escenarios se incorporaron en el programa @Risk®, con simulaciones múltiples mediante el análisis Monte Carlo. Para el análisis de sensibilidad se aplicó la prueba de correlación de Pearson. RESULTADOS: La frecuencia estimada de canales con ECvt-SUH fue 0,37 (IC95%: 0,26 a 0,58) y la carga final de ECvt-SUH fue 0,47 log ufc/canal (IC95%: -2,46 a 3,62). Las variables más fuertemente relacionadas fueron: el sistema de engorde (r = -0,681) y la concentración teórica de ECvt-SUH en la piel de los bovinos (r = 0,702). La vacunación de los animales redujo en 54,1% la frecuencia de ECvt-SUH en las canales, aunque la carga final de ECvt-SUH no sufrió cambios significativos. El duchado de las canales redujo la carga final en 0,42 log ufc/canal con respecto al modelo basal, sin modificar la frecuencia. Un incremento en la proporción de animales engordados en corrales hasta 50-60% aumentaría un 15-23% la frecuencia de canales contaminadas con ECvt-SUH. CONCLUSIONES: La vacunación de los animales resultó el escenario más eficaz para reducir el ingreso de la bacteria en la cadena agroindustrial de la carne bovina. La intensificación de la producción ganadera incrementará el riesgo a la salud pública por una mayor exposición a ECvt-SUH.<hr/>OBJECTIVES: Quantify contamination by verotoxin-producing Escherichia coli associated with hemolytic uremic syndrome (VTEC-HUS) in cattle carcasses and generate estimates of exposure in three likely scenarios. METHODS: A model was constructed of the frequency and magnitude of VTEC-HUS contamination from primary production to the removal of the carcasses from cold storage, based on the published scientific information, epidemiological data, and information from local experts. The probability distributions that best described each step in the process and scenarios were input to the @Risk® program with multiple simulations using Monte Carlo analysis. Pearson´s correlation test was used for the sensitivity analysis. RESULTS: The estimated frequency of carcasses with VTEC-HUS was 0.37 (95% CI: 0.26 to 0.58) and the final load of VTEC-HUS was 0.47 log CFU/carcass (95% CI: -2.46 to 3.62). The most closely related variables were the fattening system (r = -0.681) and the theoretical concentration of VTEC-HUS on the cattle's skin (r = 0.702). Vaccinating the animals reduced the frequency of VTEC-HUS in the carcasses by 54.1%, although there were no significant changes in the final VTEC-HUS load. Washing the carcasses reduced the final load by 0.42 log CFU/carcass compared with the baseline model, without any change in the frequency. A 50%-60% increase in the percentage of animals fattened in pens would increase the frequency of carcasses contaminated with VTEC-HUS by 15%-23%. CONCLUSIONS: Vaccinating the animals was the most effective scenario for reducing introduction of the bacteria in the beef production chain. Intensifying livestock production will increase the public health risk due to greater exposure to VTEC-HUS. <![CDATA[<b>Enteroparasite contamination in peridomiciliar soils of two indigenous territories, State of Paraná, southern Brazil</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600002&lng=en&nrm=iso&tlng=en OBJECTIVES: To determine 1) the degree of soil contamination by parasites; 2) the prevalence of contaminated samples; 3) the overall number of parasitic forms, by distance between the collection site and the domicile; 4) the mean number of parasite forms per peri-household area; and 5) the variables associated with the total number of parasite forms. METHODS: Soil samples were collected in the peridomicile of 18 (out of a total sample of 63) and 22 (out of 190) residences of the Faxinal and Ivaí indigenous territories (ITs), respectively, from March 2005 through October 2006, and evaluated by the methods of Baermann, modified Faust et al., and Lutz. RESULTS: The overall prevalence of samples contaminated by enteroparasites of humans or of animals with zoonotic potential was 75.7% (84 out of 111) in Faxinal and 96.2% (127 out of 132) in Ivaí. The most prevalent parasites were Ascaris spp., Isospora spp., and Toxocara spp. Positive statistical associations were observed between the number of parasitic forms per domicile and the following variables: time of year (season), the presence of bathrooms in the domicile, and the presence of excrement on peridomiciliar soil. CONCLUSIONS: The high level of soil contamination in Faxinal and Ivaí 1) constitutes a potential source of parasitic infection and 2) suggests that the treatment of human and animal excreta continues to be inadequate.<hr/>OBJETIVOS: Determinar: 1) el grado de contaminación parasitaria del suelo; 2) la prevalencia de muestras contaminadas; 3) el número general de formas parasitarias, en función de la distancia entre el sitio donde se tomaron las muestras y el domicilio; 4) el número promedio de formas parasitarias por área peridomiciliar y 5) las variables relacionadas con el número total de formas parasitarias. MÉTODOS: Se recogieron muestras del suelo de los alrededores de 18 (de una muestra total de 63) y 22 domicilios (de una muestra total de 190) situados en los territorios indígenas Faxinal e Ivaí, respectivamente, entre marzo del 2005 y octubre del 2006. Las muestras se evaluaron mediante los métodos propuestos por Baermann, Faust et al. (modificado) y Lutz. RESULTADOS: La prevalencia general de las muestras contaminadas por enteroparásitos humanos o animales que se consideraron de potencial zoonótico fue de 75,7% (84 de 111) en Faxinal y de 96,2% (127 de 132) en Ivaí. Las especies de parásitos más prevalentes fueron Ascaris, Isospora y Toxocara. Se observó una asociación estadística positiva entre el número de formas parasitarias halladas en los alrededores de cada domicilio y las siguientes variables: la época del año (estación), la existencia de baños domiciliarios y el hallazgo de excremento en el suelo peridomiciliar. CONCLUSIONES: La gran contaminación del suelo hallada en Faxinal e Ivaí constituye una posible fuente de infección parasitaria e indica que sigue siendo insuficiente el tratamiento de los excrementos de seres humanos y animales. <![CDATA[<b>Conceptual model for identifying factors relevant to the safety of children in school buses</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600003&lng=en&nrm=iso&tlng=en OBJETIVO: Elaborar un modelo conceptual que permita comprender las relaciones entre las variables que llevan a los niños a adoptar posturas en los vehículos de transporte escolar que incrementan los efectos lesivos en caso de accidentes de tránsito. MÉTODOS: Para la identificación de las variables se recolectó información directa de la actividad del transporte escolar por medio de grupos de enfoque, con asistentes de ruta y conductores de estos vehículos, la filmación interior de autobuses durante el transporte de los niños, y el registro de dimensiones de componentes en diferentes tipos de autobuses escolares. El análisis de la información recolectada se hizo mediante el software Atlas ti v6 y, la construcción del modelo, por medio de un proceso deductivo. RESULTADOS: Se encontraron relaciones importantes entre la adopción de posturas potencialmente riesgosas por parte de los niños durante el transporte escolar y las características dimensionales de los asientos y cinturones de seguridad, las características del servicio de transporte y el rol del asistente de ruta. CONCLUSIONES: Para llevar a cabo intervenciones coherentes y específicas en el ámbito de la seguridad en el transporte escolar, se deben considerar no solo aspectos técnicos concernientes al vehículo o condiciones posturales controladas en pruebas de choque en laboratorio, sino también las variables específicas de la actividad que llevan a los niños a adoptar posturas que incrementan el riesgo de lesiones.<hr/>OBJECTIVE: Prepare a conceptual model that facilitates understanding of the relationships between the variables that lead children to adopt postures in school transportation vehicles that increase injuries in traffic accidents. METHODS: For identification of the variables, direct information on school transportation was collected through focus groups, with bus aides and bus drivers, on-board filming during the transport of children, and recording of the dimensions of components in different types of school buses. The information collected was analyzed using the Atlas.ti v6 software and the construction of a model through deduction. RESULTS: Important relationships were found between adoption of potentially hazardous postures by children during transport to and from school and the seat and seat belt dimensions, the characteristics of the transportation service, and the role of bus aides. CONCLUSIONS: In order to adopt coherent interventions in school transportation safety, it is necessary to consider not only the technical aspects of the vehicle or posture that are controlled in crash tests but the specific variables of the activities that lead children to adopt postures that put them at greater risk of injury. <![CDATA[<b>Multigenerational inheritance and clinical characteristics of three large pedigrees with early-onset type 2 diabetes in Jamaica</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600004&lng=en&nrm=iso&tlng=en OBJECTIVE: To document the existence and clinical characteristics of three large families with multigenerational inheritance of early-onset type 2 diabetes in Jamaica. METHODS: Three probands from large families with multigenerational inheritance of early-onset type 2 diabetes in at least three generations were detected at the University Hospital of the West Indies in Jamaica. Each proband at the time of diagnosis was < 25 years of age, was lean, and did not require insulin therapy. Clinical, metabolic, and genetic assessments were undertaken to profile the diabetes in the three families. RESULTS: Three pedigrees-BK, SU, and CA-consisting of 38, 48, and 113 members, respectively, with multigenerational inheritance of early-onset type 2 diabetes in at least three generations, were investigated. The mean age at diagnosis of the three pedigrees was 31.5 ± 2.9 years, with 10 persons detected below 25 years of age. Findings suggestive of overweight, insulin resistance, low insulin secretion, dyslipidemia, and mild intra-abdominal obesity were present. Islet cell antibodies and sequence variants in MODY1 to -6 genes were absent. CONCLUSIONS: Large families demonstrating multigenerational inheritance of diabetes and other characteristics consistent with early-onset type 2 diabetes are present in the Jamaican population.<hr/>OBJETIVO: Documentar la presencia de herencia multigeneracional de la diabetes de tipo II de inicio temprano en tres familias jamaiquinas grandes y describir sus características clínicas. MÉTODOS: En el Hospital Universitario de West Indies en Jamaica, se detectaron tres probandos de familias grandes en las que se observó herencia multigeneracional de la diabetes tipo 2 de inicio temprano en al menos tres generaciones. Al momento del diagnóstico, cada probando tenía # 25 años de edad, era delgado y no necesitó insulinoterapia. Se emprendieron estudios clínicos, metabólicos y genéticos con el fin de determinar las características particulares de la diabetes que presentan estas tres familias. RESULTADOS: Se investigaron tres árboles genealógicos -BK, SU y CA- conformados por 38, 48 y 113 miembros, respectivamente. Cada árbol presentaba herencia multigeneracional de diabetes tipo 2 de inicio temprano en al menos tres generaciones. En los tres árboles genealógicos, la media de la edad al momento del diagnóstico fue de 31,5 ± 2,9 años y 10 personas tenían menos de 25 años. Se observaron signos indicativos de sobrepeso, resistencia insulínica, baja secreción de insulina, dislipidemia y obesidad intrabdominal leve. No se hallaron anticuerpos contra las células de los islotes ni variantes en la secuencia de los genes MODY1 a MODY6. CONCLUSIONES: Algunas familias grandes de la población jamaiquina presentan herencia multigeneracional de la diabetes y otras características indicativas de diabetes tipo 2 de inicio temprano. <![CDATA[<b>Public financing of health research in five Latin American countries</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600005&lng=en&nrm=iso&tlng=en OBJETIVOS: Describir los subsistemas públicos de los Sistemas Nacionales de Investigación en Salud (SNIS) en cinco países de América Latina (Argentina, Bolivia, Chile, Paraguay y Uruguay), con énfasis en los tipos de arreglos institucionales que se observan en cada país para promover, desarrollar y sostener sus SNIS, así como en los mecanismos explícitos o implícitos de priorización de proyectos de investigación en salud. MÉTODOS: Se identificó a los organismos responsables de manejar los recursos públicos destinados a financiar proyectos de investigación en salud en los cinco países estudiados. Luego se analizaron los tipos de proyectos que fueron financiados -utilizando una matriz por área y objeto de estudio-, ciertas características de los investigadores principales y los montos asignados entre 2002 y 2006. RESULTADOS: Solamente los países con mayores recursos o con redes de investigadores más desarrolladas poseen estructuras formales de asignación de fondos, con convocatorias periódicas y reglas estables, y ninguno cuenta con mecanismos explícitos e integrales de priorización para la investigación en salud. A su vez, las prioridades de investigación en salud presentan diferencias importantes entre países. En este sentido, es notorio que ciertos problemas, como "nutrición y medio ambiente" o "violencia y accidentes", reciban escasa atención en la mayoría de los países, al igual que varios temas de salud pública en algunos otros. Contrariamente, la investigación referida a "ciencias básicas" absorbe hasta un tercio de los recursos totales para investigación. CONCLUSIONES: Surgen numerosos interrogantes acerca de la capacidad de estos países para adaptar y generar nuevos conocimientos, y de la casi inexistente investigación sobre condicionantes sociales, económicos y culturales o sobre servicios y sistemas de salud, de alto impacto en grupos con acceso limitado al cuidado de la salud. Es necesario establecer explícitamente las prioridades en la agenda de investigación en salud, en consenso con las partes interesadas, así como incorporar mecanismos de monitoreo y seguimiento por temas y áreas de estudio del financiamiento de la investigación en este campo.<hr/>OBJECTIVES: Describe the public subsystems of the national health research systems (SNIS) in five Latin American countries (Argentina, Bolivia, Chile, Paraguay, and Uruguay), emphasizing the types of institutional arrangements in place in each country to promote, develop, and sustain their SNIS, as well as explicit or implicit mechanisms for prioritizing health research projects. METHODS: The bodies responsible for managing the public resources allocated to finance health research projects in the five countries studied were identified. The types of projects financed were then analyzed-using a matrix constructed by area and object of study-, certain characteristics of the principal investigators, and the sums allocated between 2002 and 2006. RESULTS: Only the countries with greater resources or better developed networks of investigators have formal structures for allocating funds with regular calls for proposals and fixed rules. None of them has explicit comprehensive mechanisms for prioritizing health research. Moreover, the health research priorities in the countries vary widely. In this regard, it is significant that problems such as "nutrition and the environment" or "violence and accidents" receive little attention in most countries. The same holds true for a number of public health issues in some countries. In contrast, the research in the "hard sciences" absorbs up to one-third of the total resources for research. CONCLUSIONS: Many questions arise about the ability of these countries to adapt and generate new knowledge, as well as the nearly nonexistent research on social, economic, and cultural determinants, or on health services and systems that have a high impact on groups with limited access to health care. Explicit priorities should be set with stakeholders for the health research agenda, and mechanisms should be adopted for monitoring and following up health research financing by subject and area of study. <![CDATA[<b>Direct immunofluorescence assay performance in diagnosis of the <i>Influenza</i> A(H1N1) virus</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600006&lng=en&nrm=iso&tlng=en El 25 de abril de 2009, a menos de un mes de la detección en México del primer humano con virus Influenza A(H1N1), la enfermedad ya se había propagado a más de 40 países superando los 10 000 casos notificados. Dada su naturaleza impredecible, este tipo de virus requiere métodos diagnósticos apropiados, confiables y seguros, pero que también estén al alcance de los laboratorios clínicos. Mediante el estudio de 291 muestras de pacientes con sospecha de infección por virus Influenza A(H1N1) en Neuquén, Argentina, el presente trabajo compara los dos métodos de diagnóstico utilizados simultáneamente: la prueba de inmunofluorescencia directa (DFA) y la de reacción en cadena de la polimerasa en tiempo real (RT-PCR). La DFA dio una sensibilidad de 44,4%, especificidad de 99,6%, valor predictivo positivo de 95,2% y valor predictivo negativo de 90,7%. Los resultados positivos de la metodología pueden considerarse verdaderos positivos. Un resultado negativo no excluye la presencia del virus y la muestra debe examinarse mediante RT-PCR. Del total de 291 muestras, 45 resultaron positivas por RT-PCR y 21 por DFA.<hr/>By 25 April 2009, less than one month after the first human with Influenza A(H1N1) virus was detected in Mexico, the disease had already spread to more than 40 countries, with over 10 000 cases reported. Due to its unpredictability, this type of virus requires appropriate, reliable, and safe diagnostic methods that are also accessible to clinical laboratories. Through the analysis of 291 samples taken from patients with suspected Influenza A(H1N1) virus infection in Neuquén, Argentina, this study compares the two diagnostic methods used simultaneously: direct immunofluorescence assay (DFA) and real-time polymerase chain reaction (RT-PCR). DFA had a sensitivity of 44.4%, a specificity of 99.6%, a positive predictive value of 95.2%, and a negative predictive value of 90.7%. Positive results obtained with this method can be considered true positives. A negative result does not rule out the presence of the virus. In this case, the sample should be examined by RT-PCR. Out of a total of 291 samples, there were 45 positive results with RT-PCR and 21 positive results with DFA. <![CDATA[<b>Sporotrichosis</b>: <b>development and challenges of an epidemic</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600007&lng=en&nrm=iso&tlng=en A ocorrência de esporotricose em animais e sua transmissão ao ser humano têm sido relatadas em diversos países. Contudo, em nenhum lugar a doença assumiu proporções epidêmicas, envolvendo pessoas e gatos, como no Estado do Rio de Janeiro, Brasil. Dados preliminares apontam para aproximadamente 2200 casos humanos diagnosticados até dezembro de 2009. No Laboratório de Pesquisa Clínica em Dermatozoonoses em Animais Domésticos foram atendidos, até essa data, aproximadamente 3244 gatos. A distribuição geográfica mostra concentração de casos na região metropolitana da Cidade do Rio de Janeiro. O grupo mais acometido são as mulheres de baixo nível socioeconômico, com idade de 40 a 59 anos, que realizam atividades domésticas. O itraconazol foi a droga de primeira escolha para o tratamento. Embora a esporotricose normalmente não acometa órgãos além da pele, mucosa e subcutâneo, tem um custo social indireto - pelo absenteísmo ao trabalho, pelo sofrimento durante a doença ativa e pelo aspecto desagradável das lesões cicatriciais. Por sua vez, nos gatos, é comum o acometimento sistêmico, levando a formas graves de difícil tratamento e evolução para o óbito. Considerando que o tempo de tratamento dos animais é maior do que nos seres humanos, tratar gatos com esporotricose tem sido um dos maiores entraves e permanece como o grande desafio para o controle da epidemia.<hr/>In the state of Rio de Janeiro, Brazil, sporotrichosis reached epidemic levels, involving humans and cats. Preliminary data indicate that approximately 2200 human cases were diagnosed between 1998 and December of 2009, and 3244 cats were treated. The geographic distribution of cases reveals a concentration in the City of Rio de Janeiro metropolitan area. The disease affects mostly women of a low socioeconomic status, aged 40 to 55 years, who work as housekeepers. Itraconazole has been the drug of choice for treatment. Although sporotrichosis does not usually affect organs other than the skin, mucosa, and subcutaneous tissue, it has an indirect social impact resulting from absenteeism, pain, and discomfort during the active disease stage, and the unpleasant appearance of the scars. In turn, systemic involvement is frequent in cats, leading to serious and difficult- to-treat forms of the disease and death. Considering that treatment time in animals is longer than in human beings, treating cats with sporotrichosis has been the greatest obstacle and the most important challenge for the control of this epidemic infection. <![CDATA[<b>Rocky Mountain spotted fever in Brazil</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600008&lng=en&nrm=iso&tlng=en Embora no Brasil o número de casos confirmados de febre maculosa esteja em declínio desde 2005, a taxa de mortalidade (20 a 30%) ainda é muito alta quando comparada a outros países. Esse alto índice de mortalidade tem estreita relação com a dificuldade em fazer o diagnóstico e estabelecer a terapia apropriada. Apenas dois grupos de antibióticos têm comprovada eficácia clínica, o cloranfenicol e as tetraciclinas. Até pouco tempo atrás, as tetraciclinas eram reservadas aos pacientes adultos em virtude das alterações dentárias e ósseas em crianças. Recentemente, entretanto, a Academia Americana de Pediatria e diversos autores têm recomendado a utilização da doxiciclina também em crianças. Em casos mais severos, a falta de experiência com uma tetraciclina injetável no Brasil faz com que se opte pelo cloranfenicol injetável. Como o pronto diagnóstico e a escolha adequada do fármaco são fatores determinantes de um prognóstico positivo, todos os profissionais da saúde devem estar melhor preparados para reconhecer e tratar a febre maculosa.<hr/>Although the number of confirmed cases of spotted fever has been declining in Brazil since 2005, the mortality rate (20% to 30%) is still high in comparison to other countries. This high mortality rate is closely related to the difficulty in making the diagnosis and starting the correct treatment. Only two groups of antibiotics have proven clinical effectiveness against spotted fever: chloramphenicol and tetracyclines. Until recently, the use of tetracyclines was restricted to adults because of the associated bone and tooth changes in children. Recently, however, the American Academy of Pediatrics and various researchers have recommended the use of doxycycline in children. In more severe cases, chloramphenicol injections are often preferred in Brazil because of the lack of experience with injectable tetracycline. Since early diagnosis and the adequate drug treatment are key to a good prognosis, health care professionals must be better prepared to recognize and treat spotted fever. <![CDATA[<b>Needlestick injuries among sanitation workers in Mexico City</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600009&lng=en&nrm=iso&tlng=en Embora no Brasil o número de casos confirmados de febre maculosa esteja em declínio desde 2005, a taxa de mortalidade (20 a 30%) ainda é muito alta quando comparada a outros países. Esse alto índice de mortalidade tem estreita relação com a dificuldade em fazer o diagnóstico e estabelecer a terapia apropriada. Apenas dois grupos de antibióticos têm comprovada eficácia clínica, o cloranfenicol e as tetraciclinas. Até pouco tempo atrás, as tetraciclinas eram reservadas aos pacientes adultos em virtude das alterações dentárias e ósseas em crianças. Recentemente, entretanto, a Academia Americana de Pediatria e diversos autores têm recomendado a utilização da doxiciclina também em crianças. Em casos mais severos, a falta de experiência com uma tetraciclina injetável no Brasil faz com que se opte pelo cloranfenicol injetável. Como o pronto diagnóstico e a escolha adequada do fármaco são fatores determinantes de um prognóstico positivo, todos os profissionais da saúde devem estar melhor preparados para reconhecer e tratar a febre maculosa.<hr/>Although the number of confirmed cases of spotted fever has been declining in Brazil since 2005, the mortality rate (20% to 30%) is still high in comparison to other countries. This high mortality rate is closely related to the difficulty in making the diagnosis and starting the correct treatment. Only two groups of antibiotics have proven clinical effectiveness against spotted fever: chloramphenicol and tetracyclines. Until recently, the use of tetracyclines was restricted to adults because of the associated bone and tooth changes in children. Recently, however, the American Academy of Pediatrics and various researchers have recommended the use of doxycycline in children. In more severe cases, chloramphenicol injections are often preferred in Brazil because of the lack of experience with injectable tetracycline. Since early diagnosis and the adequate drug treatment are key to a good prognosis, health care professionals must be better prepared to recognize and treat spotted fever. <![CDATA[<b>De las definiciones, las vacunas y la identificación del paciente séptico en pediatría</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600010&lng=en&nrm=iso&tlng=en Embora no Brasil o número de casos confirmados de febre maculosa esteja em declínio desde 2005, a taxa de mortalidade (20 a 30%) ainda é muito alta quando comparada a outros países. Esse alto índice de mortalidade tem estreita relação com a dificuldade em fazer o diagnóstico e estabelecer a terapia apropriada. Apenas dois grupos de antibióticos têm comprovada eficácia clínica, o cloranfenicol e as tetraciclinas. Até pouco tempo atrás, as tetraciclinas eram reservadas aos pacientes adultos em virtude das alterações dentárias e ósseas em crianças. Recentemente, entretanto, a Academia Americana de Pediatria e diversos autores têm recomendado a utilização da doxiciclina também em crianças. Em casos mais severos, a falta de experiência com uma tetraciclina injetável no Brasil faz com que se opte pelo cloranfenicol injetável. Como o pronto diagnóstico e a escolha adequada do fármaco são fatores determinantes de um prognóstico positivo, todos os profissionais da saúde devem estar melhor preparados para reconhecer e tratar a febre maculosa.<hr/>Although the number of confirmed cases of spotted fever has been declining in Brazil since 2005, the mortality rate (20% to 30%) is still high in comparison to other countries. This high mortality rate is closely related to the difficulty in making the diagnosis and starting the correct treatment. Only two groups of antibiotics have proven clinical effectiveness against spotted fever: chloramphenicol and tetracyclines. Until recently, the use of tetracyclines was restricted to adults because of the associated bone and tooth changes in children. Recently, however, the American Academy of Pediatrics and various researchers have recommended the use of doxycycline in children. In more severe cases, chloramphenicol injections are often preferred in Brazil because of the lack of experience with injectable tetracycline. Since early diagnosis and the adequate drug treatment are key to a good prognosis, health care professionals must be better prepared to recognize and treat spotted fever. <![CDATA[<b>Maternal and congenital syphilis in haiti</b>: <b>a big problem</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600011&lng=en&nrm=iso&tlng=en Embora no Brasil o número de casos confirmados de febre maculosa esteja em declínio desde 2005, a taxa de mortalidade (20 a 30%) ainda é muito alta quando comparada a outros países. Esse alto índice de mortalidade tem estreita relação com a dificuldade em fazer o diagnóstico e estabelecer a terapia apropriada. Apenas dois grupos de antibióticos têm comprovada eficácia clínica, o cloranfenicol e as tetraciclinas. Até pouco tempo atrás, as tetraciclinas eram reservadas aos pacientes adultos em virtude das alterações dentárias e ósseas em crianças. Recentemente, entretanto, a Academia Americana de Pediatria e diversos autores têm recomendado a utilização da doxiciclina também em crianças. Em casos mais severos, a falta de experiência com uma tetraciclina injetável no Brasil faz com que se opte pelo cloranfenicol injetável. Como o pronto diagnóstico e a escolha adequada do fármaco são fatores determinantes de um prognóstico positivo, todos os profissionais da saúde devem estar melhor preparados para reconhecer e tratar a febre maculosa.<hr/>Although the number of confirmed cases of spotted fever has been declining in Brazil since 2005, the mortality rate (20% to 30%) is still high in comparison to other countries. This high mortality rate is closely related to the difficulty in making the diagnosis and starting the correct treatment. Only two groups of antibiotics have proven clinical effectiveness against spotted fever: chloramphenicol and tetracyclines. Until recently, the use of tetracyclines was restricted to adults because of the associated bone and tooth changes in children. Recently, however, the American Academy of Pediatrics and various researchers have recommended the use of doxycycline in children. In more severe cases, chloramphenicol injections are often preferred in Brazil because of the lack of experience with injectable tetracycline. Since early diagnosis and the adequate drug treatment are key to a good prognosis, health care professionals must be better prepared to recognize and treat spotted fever. <![CDATA[<b>Erratum</b>]]> http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000600012&lng=en&nrm=iso&tlng=en Embora no Brasil o número de casos confirmados de febre maculosa esteja em declínio desde 2005, a taxa de mortalidade (20 a 30%) ainda é muito alta quando comparada a outros países. Esse alto índice de mortalidade tem estreita relação com a dificuldade em fazer o diagnóstico e estabelecer a terapia apropriada. Apenas dois grupos de antibióticos têm comprovada eficácia clínica, o cloranfenicol e as tetraciclinas. Até pouco tempo atrás, as tetraciclinas eram reservadas aos pacientes adultos em virtude das alterações dentárias e ósseas em crianças. Recentemente, entretanto, a Academia Americana de Pediatria e diversos autores têm recomendado a utilização da doxiciclina também em crianças. Em casos mais severos, a falta de experiência com uma tetraciclina injetável no Brasil faz com que se opte pelo cloranfenicol injetável. Como o pronto diagnóstico e a escolha adequada do fármaco são fatores determinantes de um prognóstico positivo, todos os profissionais da saúde devem estar melhor preparados para reconhecer e tratar a febre maculosa.<hr/>Although the number of confirmed cases of spotted fever has been declining in Brazil since 2005, the mortality rate (20% to 30%) is still high in comparison to other countries. This high mortality rate is closely related to the difficulty in making the diagnosis and starting the correct treatment. Only two groups of antibiotics have proven clinical effectiveness against spotted fever: chloramphenicol and tetracyclines. Until recently, the use of tetracyclines was restricted to adults because of the associated bone and tooth changes in children. Recently, however, the American Academy of Pediatrics and various researchers have recommended the use of doxycycline in children. In more severe cases, chloramphenicol injections are often preferred in Brazil because of the lack of experience with injectable tetracycline. Since early diagnosis and the adequate drug treatment are key to a good prognosis, health care professionals must be better prepared to recognize and treat spotted fever.